Ian C. Scott

1.1k total citations
17 papers, 301 citations indexed

About

Ian C. Scott is a scholar working on Immunology, Surgery and Emergency Medical Services. According to data from OpenAlex, Ian C. Scott has authored 17 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Surgery and 3 papers in Emergency Medical Services. Recurrent topics in Ian C. Scott's work include IL-33, ST2, and ILC Pathways (13 papers), Eosinophilic Esophagitis (8 papers) and Immune Cell Function and Interaction (6 papers). Ian C. Scott is often cited by papers focused on IL-33, ST2, and ILC Pathways (13 papers), Eosinophilic Esophagitis (8 papers) and Immune Cell Function and Interaction (6 papers). Ian C. Scott collaborates with scholars based in United Kingdom, United States and Sweden. Ian C. Scott's co-authors include E. Suzanne Cohen, Jayesh B. Majithiya, Dominic J. Corkill, Philip N. Sanders, Tom Moore, Jonas S. Erjefält, Caroline Sandén, Peter Thornton, Andrew N. J. McKenzie and Helen E. Jolin and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Ian C. Scott

15 papers receiving 301 citations

Peers

Countries citing papers authored by Ian C. Scott

Since Specialization

Citations

This map shows the geographic impact of Ian C. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian C. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian C. Scott more than expected).

Fields of papers citing papers by Ian C. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian C. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian C. Scott. The network helps show where Ian C. Scott may publish in the future.

Co-authorship network of co-authors of Ian C. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Ian C. Scott. A scholar is included among the top collaborators of Ian C. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian C. Scott. Ian C. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum 2025 ·Bioanalysis ·Weiwen Sun, Si Mou, (unknown), (unknown), Ian C. Scott, Aoife Kelly, Monica L. Gavala, (unknown), (unknown), Neil E. Alexis, (unknown), (unknown), (unknown), Moucun Yuan, William Mylott, Kévin Contrepois, Anton I. Rosenbaum	1
2	Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease 2024 ·British Journal of Clinical Pharmacology ·Muhammad Waqas Sadiq, (unknown), Magnus Åstrand, Ian C. Scott, Adam Williams, (unknown), N. E. White, (unknown), Monica L. Gavala, E. Suzanne Cohen, (unknown), Chris Kell, Hitesh Pandya, (unknown)	2
3	Distinct Pharmacological Profiles of IL-33 Antibodies 2024 ·(unknown), (unknown), Ian C. Scott, Albert R. Collinson, D. Jasper G. Rees, (unknown), (unknown), Elizabeth C. Hinchy	0
4	Tozorakimab (Anti-IL-33) Rebalances COPD Epithelium Enhancing Club Cell Activities and Reshaping Viral Responses 2023 ·Xavier Romero Ros, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ian C. Scott, (unknown)	1
5	Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine 2023 ·Nature Communications ·Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Victor Augusti Negri, (unknown), (unknown), (unknown), David J. Jackson, Katja Höschler, Tina Baker, Ian C. Scott, Xavier Romero Ros, (unknown), Maria Zambon, Katrina M. Pollock, Trevor T. Hansel, Peter Openshaw	28
6	Altered Differentiation and Inflammation Profiles Contribute to Enhanced Innate Responses in Severe COPD Epithelium to Rhinovirus Infection 2022 ·Frontiers in Medicine ·Hong Guo-Parke, Dermot Linden, Aurélie Mousnier, Ian C. Scott, (unknown), Lee A. Borthwick, Andrew J. Fisher, Sinéad Weldon, Clifford C. Taggart, Joseph C. Kidney	4
7	Oxidised IL-33 signals via RAGE/EGFR to drive a COPD-associated phenotype 2022 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ian C. Scott, (unknown), E. Suzanne Cohen	4
8	Tozorakimab: a dual-pharmacology anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction 2022 ·Ian C. Scott, Elizabeth England, D. Gareth Rees, (unknown), (unknown), (unknown), Dorothy A. Sims, (unknown), Elizabeth C. Hinchy, (unknown), D Corkill, E. Suzanne Cohen	4
9	Proof of Mechanism for Anti-Interleukin-33 Antibody Tozorakimab in a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease 2022 ·Ian C. Scott, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
10	Safety, Pharmacokinetics and Immunogenicity of the Anti-Interleukin-33 Antibody, Tozorakimab: Results of a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease 2022 ·(unknown), Dileep Kumar Singh, Muna Albayaty, (unknown), (unknown), Muhammad Waqas Sadiq, (unknown), Ian C. Scott, (unknown), (unknown), A. Godwood, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
11	Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages 2020 ·Immunity ·Yuning Lu, Gemma Basatemur, Ian C. Scott, Davide Chiarugi, Marc Clément, James Harrison, Ravin Jugdaohsingh, Xianjun Yu, Stephen A. Newland, Helen E. Jolin, Xuan Li, Xiao Chen, (unknown), Guttorm Haraldsen, Gaby Palmer, Padraic G. Fallon, E. Suzanne Cohen, Andrew N. J. McKenzie, Ziad Mallat	35
12	A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue 2019 ·The Journal of Experimental Medicine ·Batika M.J. Rana, Eric Jou, Jillian L. Barlow, Noé Rodríguez‐Rodríguez, Jennifer A. Walker, (unknown), Helen E. Jolin, Clare S. Hardman, (unknown), Aydan C. H. Szeto, E. Suzanne Cohen, Ian C. Scott, Matthew A. Sleeman, (unknown), Sara Cruz Migoni, Jorge Caamaño, Helle F. Jørgensen, Stefania Carobbio, Antonio Vidal‐Puig, Andrew N. J. McKenzie	98
13	Novel assays to measure forms of interleukin-33 in the circulation and airway mucosa 2019 ·Ian C. Scott, (unknown), (unknown), (unknown), (unknown), Trevor T. Hansel, (unknown), Ryan S. Thwaites, E. Suzanne Cohen	2
14	New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors 2018 ·Biochemical Society Transactions ·Ian C. Scott, (unknown), E. Suzanne Cohen	11
15	Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage 2018 ·Scientific Reports ·Ian C. Scott, Jayesh B. Majithiya, Caroline Sandén, Peter Thornton, Philip N. Sanders, Tom Moore, (unknown), Dominic J. Corkill, Jonas S. Erjefält, E. Suzanne Cohen	84
16	LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation 2015 ·(unknown), Ian C. Scott, Jayesh B. Majithiya, Laura Rapley, Benjamin Kemp, Nicholas J. Bond, Dorothy A. Sims, Christopher E. Brightling, Robin Butler, Daniel R. Higazi, Dominic J. Corkill, Richard May, Tomas Mustelin, Matthew A. Sleeman	7
17	Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1β-driven model of joint pathology 2008 ·Osteoarthritis and Cartilage ·Ian C. Scott, Anita Midha, Umer Rashid, Simon Ball, Andrew Walding, P J Kerry, Stephen J. Delaney, Simon Cruwys	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact